Greenlight Re Reports Strong Q1 Earnings, Executes $14.5M in Share Repurchases
Summary
Greenlight Capital Re announced strong Q1 2026 financial results, including a significant increase in net income and an improved combined ratio, alongside the execution of $14.5 million in share repurchases.
Key Events
-
Strong Q1 2026 Financial Performance
Net income increased to $35.8 million ($1.05 per diluted share) in Q1 2026, up from $29.6 million ($0.86 per diluted share) in Q1 2025.
-
Significant Underwriting Turnaround
The combined ratio improved to 96.0% in Q1 2026, a notable improvement from 104.6% in the prior year, indicating disciplined profitability.
-
Increased Book Value Per Share
Fully diluted book value per share grew by 4.7% to $21.40 as of March 31, 2026, from $20.43 at December 31, 2025.
-
Substantial Share Repurchases
The company repurchased $5 million of ordinary shares in Q1 2026 at an average cost of $16.70 per share, and an additional $9.5 million in April 2026 at an average price of $18.38 per share, totaling $14.5 million in repurchases.
Analysis
Greenlight Capital Re reported significantly improved financial results for the first quarter of 2026, demonstrating a strong turnaround in underwriting performance with a combined ratio of 96.0% compared to 104.6% in the prior year. Net income increased substantially to $35.8 million, or $1.05 per diluted share, from $29.6 million, or $0.86 per diluted share. The company also saw its fully diluted book value per share increase by 4.7% to $21.40. Furthermore, Greenlight Re actively returned capital to shareholders by repurchasing $5 million of ordinary shares in Q1 and an additional $9.5 million in April, totaling $14.5 million. This execution represents a significant portion of the $40 million share buyback program initiated on May 5, 2026, signaling strong management confidence and a commitment to shareholder value.
At the time of this filing, GLRE was trading at $17.90 on NASDAQ in the Finance sector, with a market capitalization of approximately $608.3M. The 52-week trading range was $11.57 to $19.39. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.